Patents by Inventor Michela Parth

Michela Parth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGON'S DISEASE
    Publication number: 20220073650
    Abstract: Disclosed is an apheresis device including a solid carrier capable of being contacted with the blood or plasma flow, characterised in that the solid carrier includes one or several HTT-binding molecule (s) capable of adsorbing HTT or fragments thereof in a specific manner from plasma or blood or other HTT containing body fluids such as CSF.
    Type: Application
    Filed: November 5, 2021
    Publication date: March 10, 2022
    Applicant: AFFIRIS AG
    Inventors: Oskar SMRZKA, Stefan BARTL, Michela PARTH
  • SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE
    Publication number: 20210040236
    Abstract: Disclosed is an apheresis device including a solid carrier capable of being contacted with the blood or plasma flow, characterised in that the solid carrier includes one or several HTT-binding molecule(s) capable of adsorbing HTT or fragments thereof in a specific manner from plasma or blood or other HTT containing body fluids such as CSF.
    Type: Application
    Filed: August 18, 2020
    Publication date: February 11, 2021
    Applicant: AFFIRIS AG
    Inventors: Oskar SMRZKA, Stefan Bartl, Michela Parth
  • Substances and methods for the use in prevention and/or treatment in Huntington's disease
    Patent number: 10406197
    Abstract: Disclosed are immunogenic peptides of the HTT protein and HTT specific antibodies for use in the prevention and/or treatment of Huntington's disease.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: September 10, 2019
    Assignee: AFFIRIS AG
    Inventors: Oskar Smrzka, Stefan Bartl, Michela Parth
  • SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE
    Publication number: 20180327513
    Abstract: Disclosed is an apheresis device including a solid carrier capable of being contacted with the blood or plasma flow, characterised in that the solid carrier includes one or several HTT-binding molecule(s) capable of adsorbing HTT or fragments thereof in a specific manner from plasma or blood or other HTT containing body fluids such as CSF.
    Type: Application
    Filed: July 2, 2018
    Publication date: November 15, 2018
    Applicant: AFFIRIS AG
    Inventors: Oskar SMRZKA, Stefan Bartl, Michela Parth
  • Substances and methods for the use in prevention and/or treatment in Huntington's disease
    Patent number: 10053518
    Abstract: Disclosed is an apheresis device comprising a solid carrier capable of being contacted with the blood or plasma flow, characterised in that the solid carrier includes one or several HTT-binding molecule(s) capable of adsorbing HTT or fragments thereof in a specific manner from plasma or blood or other HTT containing body fluids such as CSF.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: August 21, 2018
    Assignee: AFFIRIS AG
    Inventors: Oskar Smrzka, Stefan Bartl, Michela Parth